On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Charles River Laboratories Preclinical Services Edinburgh Ltd's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€326k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- SKIP-NMDPartner
A phase I/IIa clinical trial in Duchenne muscular dystrophy using systemically delivered morpholino antisense oligomer to skip exon 53
FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗
€326ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- University College LondonUnited Kingdom · 1 shared project
- University of Newcastle Upon TyneUnited Kingdom · 1 shared project
- Universita Cattolica del Sacro CuoreItaly · 1 shared project
- Royal Holloway and Bedford New CollegeUnited Kingdom · 1 shared project
- Great Ormond Street Hospital for Children Nhs Foundation TrustUnited Kingdom · 1 shared project
- Association Institut de MyologieFrance · 1 shared project
- Sarepta Therapeutics Inc CorporationUnited States · 1 shared project
- Sysnav SASFrance · 1 shared project
- Consultants for Research In Imaging and Spectroscopy ScrlBelgium · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- duchenne muscular dystrophy
- mutation
- pathology
- proteins
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗